Patents by Inventor Ann O'Neill

Ann O'Neill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230344058
    Abstract: A battery housing assembly for housing battery components of an electric vehicle includes a battery tray, a lid, and a sealant. The battery tray includes a channel located outwardly relative to the battery components. The lid is secured to the battery tray and includes an end portion disposed within the channel. The lid further includes at least one alignment feature configured to align the lid and the battery tray. The sealant is disposed within a portion of the channel of the battery tray and is configured to secure the battery tray and the lid to each other. The sealant is further configured to seal an internal cavity of the battery housing assembly.
    Type: Application
    Filed: April 21, 2022
    Publication date: October 26, 2023
    Applicant: Ford Global Technologies, LLC
    Inventors: Stuart C. Salter, Renata Michaela Arsenault, David Brian Glickman, Kent Snyder, Brian Joseph Robert, Ann O'Neill, Lorne Forsythe
  • Patent number: 11618008
    Abstract: Methods for preparing ceria-zirconia (CZO) materials calcined with precious group metals (PGM) include calcining a CZO material with PGM. The calcined CZO/PGM catalyst is reduced at a temperature of ?1000° C. to ?1100° C. for a time of ?0.5 hour to 1 hour to form a (CZO/PGM)-pyrochlore catalyst. The (CZO/PGM)-pyrochlore catalyst exhibits superior oxygen storage capacity characteristics as a three-way catalyst in vehicle exhaust gas systems.
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: April 4, 2023
    Assignee: Ford Global Technologies, LLC
    Inventors: Jason Wu, Giovanni Cavataio, Ann O'Neill, Natalie Roxas
  • Publication number: 20220105492
    Abstract: Methods for preparing ceria-zirconia (CZO) materials calcined with precious group metals (PGM) include calcining a CZO material with PGM. The calcined CZO/PGM catalyst is reduced at a temperature of ?1000° C. to ?1100° C. for a time of ?0.5 hour to 1 hour to form a (CZO/PGM)-pyrochlore catalyst. The (CZO/PGM)-pyrochlore catalyst exhibits superior oxygen storage capacity characteristics as a three-way catalyst in vehicle exhaust gas systems.
    Type: Application
    Filed: October 5, 2020
    Publication date: April 7, 2022
    Applicant: Ford Global Technologies, LLC
    Inventors: Jason Wu, Giovanni Cavataio, Ann O'Neill, Natalie Roxas
  • Patent number: 10835092
    Abstract: A vacuum cleaner attachment is disclosed having a concave vacuum head with a swivel joint that permits swiveling of the vacuum head only within the plane of the vacuum head. The concave vacuum head can have a curvature that is similar to the curvature of a cylindrical surface to be vacuumed. Thus, while a user manipulates the conduit providing the air suction to the vacuum head, the concave surface can be supported and swiveled around the circumference of the cylindrical surface to be vacuumed, while the vacuum head is also moved along the length of the cylindrical surface. Throughout this movement of the concave vacuum head, the concave opening of the concave vacuum head can stay in closer proximity and conformity to the cylindrical surface than is possible using a fixed vacuum head with a flat opening, thereby making cleaning of the cylindrical surface more effective and efficient.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: November 17, 2020
    Inventor: Patricia Ann O'Neill
  • Publication number: 20200085268
    Abstract: A vacuum cleaner attachment is disclosed having a concave vacuum head with a swivel joint that permits swiveling of the vacuum head only within the plane of the vacuum head. The concave vacuum head can have a curvature that is similar to the curvature of a cylindrical surface to be vacuumed. Thus, while a user manipulates the conduit providing the air suction to the vacuum head, the concave surface can be supported and swiveled around the circumference of the cylindrical surface to be vacuumed, while the vacuum head is also moved along the length of the cylindrical surface. Throughout this movement of the concave vacuum head, the concave opening of the concave vacuum head can stay in closer proximity and conformity to the cylindrical surface than is possible using a fixed vacuum head with a flat opening, thereby making cleaning of the cylindrical surface more effective and efficient.
    Type: Application
    Filed: November 8, 2019
    Publication date: March 19, 2020
    Inventor: Patricia Ann O'Neill
  • Publication number: 20170215669
    Abstract: A vacuum cleaner attachment is disclosed having a concave vacuum head with a swivel joint that permits swiveling of the vacuum head only within the plane of the vacuum head. The concave vacuum head can have a curvature that is similar to the curvature of a cylindrical surface to be vacuumed. Thus, while a user manipulates the conduit providing the air suction to the vacuum head, the concave surface can be supported and swiveled around the circumference of the cylindrical surface to be vacuumed, while the vacuum head is also moved along the length of the cylindrical surface. Throughout this movement of the concave vacuum head, the concave opening of the concave vacuum head can stay in closer proximity and conformity to the cylindrical surface than is possible using a fixed vacuum head with a flat opening, thereby making cleaning of the cylindrical surface more effective and efficient.
    Type: Application
    Filed: February 1, 2017
    Publication date: August 3, 2017
    Inventor: Patricia Ann O'Neill
  • Patent number: 9456985
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: October 4, 2016
    Assignee: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
  • Publication number: 20160051475
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an amine-containing compound (e.g., an opioid) (including salts thereof) and a pharmaceutically acceptable salt of a non-NSAID cyclic organic acid compound.
    Type: Application
    Filed: September 11, 2015
    Publication date: February 25, 2016
    Applicant: Upsher-Smith Laboratories, Inc.
    Inventors: Ronnie Ortiz, James S. Jensen, Kristopher R. Lundell, Victoria Ann O'Neill, Sean Mahoney
  • Publication number: 20150238423
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Application
    Filed: April 28, 2015
    Publication date: August 27, 2015
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: CHRISTIAN F. WERTZ, JAMES S. JENSEN, VICTORIA ANN O'NEILL, SEAN B. MAHONEY, STEPHEN M. BERGE
  • Publication number: 20150182462
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Application
    Filed: March 11, 2015
    Publication date: July 2, 2015
    Inventors: Kenneth L. EVENSTAD, Christian F. WERTZ, James S. JENSEN, Victoria Ann O'NEILL, Stephen M. BERGE
  • Patent number: 9023390
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: May 5, 2015
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
  • Patent number: 8987291
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: March 24, 2015
    Assignee: Upsher Smith Laboratories, Inc.
    Inventors: Kenneth L. Evenstad, Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Stephen M. Berge
  • Publication number: 20130237559
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an amine-containing compound (e.g., an opioid) (including salts thereof) and a pharmaceutically acceptable salt of a non-NSAID cyclic organic acid compound.
    Type: Application
    Filed: June 29, 2011
    Publication date: September 12, 2013
    Inventors: Ronnie Ortiz, James S. Jensen, Kristopher R. Lundell, Victoria Ann O'Neill, Sean Mahoney
  • Patent number: 8362029
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: January 29, 2013
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Kenneth L. Evenstad, Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Stephen M. Berge
  • Publication number: 20120252833
    Abstract: Sustained-release oral pharmaceutical compositions and methods of use, wherein the compositions are in a single dosage form and include an amine-containing compound (including salts thereof), a salt of a non-steroidal anti-inflammatory drug (NSAID), and a hydrophilic matrix.
    Type: Application
    Filed: December 31, 2009
    Publication date: October 4, 2012
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Sean B. Mahoney, Stephen M. Berge
  • Publication number: 20110275658
    Abstract: The present invention provides sustained-release oral pharmaceutical compositions and methods of use. The sustained-release oral pharmaceutical compositions include an opioid (including salts thereof) and a salt of a non-steroidal anti-inflammatory drug (NSAID).
    Type: Application
    Filed: December 31, 2009
    Publication date: November 10, 2011
    Applicant: UPSHER-SMITH LABORATORIES, INC.
    Inventors: Kenneth L. Evenstad, Christian F. Wertz, James S. Jensen, Victoria Ann O'Neill, Stephen M. Berge
  • Patent number: 7910698
    Abstract: The present invention provides, in part, NPC1L1 from various species. Methods of using the NPC1L1 polypeptides and polynucleotide set forth herein, e.g., in screening assays, are also set forth.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: March 22, 2011
    Assignee: Schering Corporation
    Inventors: Scott Altmann, Xiaorui Yao, Kim Ann O'Neill, Brian E. Hawes
  • Publication number: 20100221328
    Abstract: Described herein are extended-release or sustained-release formulations suitable for highly soluble pharmacologically active compounds, for example, amantadine. Dosage units for providing extended release are provided by the present invention. In some embodiments, the dosage unit comprises a plurality of coated beads having drug layer and a coating layer, wherein the coating layer comprises an ethylcellulose polymer. In some embodiments, near zero-order release of the active compound is achieved.
    Type: Application
    Filed: December 30, 2009
    Publication date: September 2, 2010
    Inventors: Christian F. Wertz, Victoria Ann O'Neill, Stephen M. Berge
  • Publication number: 20090098128
    Abstract: The present invention provides, in part, NPC1L1 from various species. Methods of using the NPC1L1 polypeptides and polynucleotide set forth herein, e.g., in screening assays, are also set forth.
    Type: Application
    Filed: February 22, 2007
    Publication date: April 16, 2009
    Inventors: Scott W. Altmann, Xiaorui Yao, Kim Ann O'Neill, Brian E. Hawes
  • Patent number: 7232910
    Abstract: The present invention relates to methods for preparing indazole compounds of formula I, which are useful as modulators and/or inhibitors of protein kinases. The present invention also relates to intermediate compounds useful in the preparation of compounds of formula I.
    Type: Grant
    Filed: October 31, 2005
    Date of Patent: June 19, 2007
    Assignee: Agouron Pharmaceuticals, Inc.
    Inventors: Brigitte Leigh Ewanicki, Erik Jon Flahive, Annie Judith Kasparian, Mark Bryan Mitchell, Michael David Perry, Stacy Ann O'Neill-Slawecki, Neal William Sach, James Edward Saenz, Bing Shi, Nebojsa Slobodan Stankovic, Jayaram Kasturi Srirangam, Qingping Tian, Shu Yu